A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anas Younes, MD
MD Anderson Cancer Center at University of Texas, Houston
Principal Investigator - Jonathan Friedberg, MD
University of Rochester James P. Wilmot Cancer Center
Principal Investigator - Julie Vose, MD
University of Nebraska
Principal Investigator - Peter Martin, MD
Weill Medical College of Cornell University
Principal Investigator - Richard Klasa, MD
British Columbia Cancer Center - Vancouver Centre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of British Columbia
Vancouver, British Columbia, Canada
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Weill Medical College of Cornell
New York, New York, United States
- University of Rochester James P. Wilmot Cancer Center
Rochester, New York, United States
- Md Anderson Cancer Canter
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 29 Feb 2012
- Completion
- 29 Feb 2012
- Last update posted
- 20 Apr 2012
- Registered enrollment
- 28
- Registry id
- NCT01263899
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.